Alnylam Pharmaceuticals Alternatives & Competitors
12 companies similar to Alnylam Pharmaceuticals — Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma...
EUSA Pharma
Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recor...
Hemel Hempstead, United K...
MeiraGTx
Engineering Hope
United Kingdom
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
BioMarin Pharmaceutical Inc.
We transform lives through genetic discovery.
San Rafael, United States
Track all Alnylam Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Roivant
Reinventing Biopharma
New York, United States
Jazz Pharmaceuticals
Identifying, developing and commercializing meaningful products that address unmet medical...
Dublin, Ireland
Ultragenyx
Going Beyond Every Day
Novato, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Cambridge, United Kingdom
Cullinan Therapeutics
Science That Moves
Cambridge, United States
About Alnylam Pharmaceuticals
Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach.
Development of RNAi-based medicines, Clinical development and trials, Patient services and support, Scientific presentations and publications
Patients with rare and prevalent diseases, Healthcare professionals, Investors, Biotech industry collaborators
RNAi Therapeutics, Biopharmaceuticals, Drug Development, Gene Silencing, Rare Disease Treatment, Innovative Medicines, Commercialized Medicines, Global Reach, Biotech Research, Therapeutics For Prevalent Diseases, Employee-Centric Culture, Diversity And Inclusion, Pioneering Research, Adverse Event Reporting, Fraudulent Recruitment Awareness
B2B, D2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Alnylam Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Alnylam Pharmaceuticals on 9 Jun 2026. The 12 companies listed here were last checked between 4 Mar 2026 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.